학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 8건 | 목록 1~20
Academic Journal
Navarro-Romero A; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Galera-López L; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Ortiz-Romero P; Department of Biomedical Sciences, School of Medicine and Health Sciences, University of Barcelona, and centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain.; Llorente-Ovejero A; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Spain.; de Los Reyes-Ramírez L; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Bengoetxea de Tena I; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Spain.; Garcia-Elias A; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Mas-Stachurska A; Hospital del Mar Medical Research Institute (IMIM), Autonomous University of Barcelona, Barcelona, Spain.; Reixachs-Solé M; EMBL Australia Partner Laboratory Network at the Australian National University, Canberra, Australia.; The John Curtin School of Medical Research, Australian National University, Canberra, Australia.; Pastor A; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; de la Torre R; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; Maldonado R; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; Benito B; Group of Cardiovascular Experimental and Translational Research (GET-CV), Vascular Biology and Metabolism, Vall d'Hebron Research Institute (VHIR),, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Instituto de Salud Carlos III, Madrid, Spain.; Eyras E; EMBL Australia Partner Laboratory Network at the Australian National University, Canberra, Australia.; The John Curtin School of Medical Research, Australian National University, Canberra, Australia.; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; Rodríguez-Puertas R; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Spain.; Neurodegenerative Diseases, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Campuzano V; Department of Biomedical Sciences, School of Medicine and Health Sciences, University of Barcelona, and centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain.; Ozaita A; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Dávila-Bouziguet E; Department of Cell Biology, Physiology and Immunology, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII), Spain.; Casòliba-Melich A; Department of Cell Biology, Physiology and Immunology, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII), Spain.; Targa-Fabra G; Department of Cell Biology, Physiology and Immunology, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII), Spain.; Galera-López L; Laboratory of Neuropharmacology-NeuroPhar, Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.; Ozaita A; Laboratory of Neuropharmacology-NeuroPhar, Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.; Maldonado R; Laboratory of Neuropharmacology-NeuroPhar, Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.; Ávila J; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII), Spain.; Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Neurobiology Laboratory, Madrid, Spain.; Delgado-García JM; Division of Neurosciences, Pablo de Olavide University, Seville, Spain.; Gruart A; Division of Neurosciences, Pablo de Olavide University, Seville, Spain.; Soriano E; Department of Cell Biology, Physiology and Immunology, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII), Spain.; Pascual M; Department of Cell Biology, Physiology and Immunology, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII), Spain.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE
Academic Journal
Gomis-González M; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003, Barcelona, Spain.; Integrative Pharmacology and Systems Neuroscience Research Group, Hospital del Mar Medical Research Institute, 08003, Barcelona, Spain.; Galera-López L; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003, Barcelona, Spain.; Ten-Blanco M; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003, Barcelona, Spain.; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, UFV, 28223, Pozuelo de Alarcón, Spain.; Busquets-Garcia A; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003, Barcelona, Spain.; Integrative Pharmacology and Systems Neuroscience Research Group, Hospital del Mar Medical Research Institute, 08003, Barcelona, Spain.; Cox T; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003, Barcelona, Spain.; Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, GU2 7WG, Guildford, UK.; Maldonado R; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003, Barcelona, Spain. rafael.maldonado@upf.edu.; IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain. rafael.maldonado@upf.edu.; Laboratori de Neurofarmacologia, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, C/ Doctor Aiguader 88, 08003, Barcelona, Spain. rafael.maldonado@upf.edu.; Ozaita A; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003, Barcelona, Spain. andres.ozaita@upf.edu.; IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain. andres.ozaita@upf.edu.; Laboratori de Neurofarmacologia, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, C/ Doctor Aiguader 88, 08003, Barcelona, Spain. andres.ozaita@upf.edu.
Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE
Academic Journal
Martínez-Torres S; Laboratory of Neuropharmacology-NeuroPhar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia. Parc Científic de Barcelona, Barcelona, Spain.; Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.; Institute of Neuroscience, University of Barcelona, Barcelona, Spain.; Bergadà-Martínez A; Laboratory of Neuropharmacology-NeuroPhar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Ortega JE; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain.; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Galera-López L; Laboratory of Neuropharmacology-NeuroPhar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Hervera A; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia. Parc Científic de Barcelona, Barcelona, Spain.; Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.; Institute of Neuroscience, University of Barcelona, Barcelona, Spain.; de Los Reyes-Ramírez L; Laboratory of Neuropharmacology-NeuroPhar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Ortega-Álvaro A; Laboratory of Neuropharmacology-NeuroPhar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.; Remmers F; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.; Muñoz-Moreno E; Experimental 7T MRI Unit, Magnetic Resonance Imaging Core Facility (IDIBAPS), Barcelona, Spain.; Soria G; Experimental 7T MRI Unit, Magnetic Resonance Imaging Core Facility (IDIBAPS), Barcelona, Spain.; Laboratory of Surgical Neuroanatomy, Faculty of Medicine and Health Sciences, Institute of Neurosciencies, University of Barcelona, Barcelona, Spain.; Del Río JA; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia. Parc Científic de Barcelona, Barcelona, Spain.; Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.; Institute of Neuroscience, University of Barcelona, Barcelona, Spain.; Lutz B; Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.; Leibniz Institute for Resilience Research (LIR), Mainz, Germany.; Ruíz-Ortega JÁ; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain.; Meana JJ; Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain.; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Maldonado R; Laboratory of Neuropharmacology-NeuroPhar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain. rafael.maldonado@upf.edu.; IMIM Hospital del Mar Research Institute, Barcelona, Spain. rafael.maldonado@upf.edu.; Ozaita A; Laboratory of Neuropharmacology-NeuroPhar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain. andres.ozaita@upf.edu.; IMIM Hospital del Mar Research Institute, Barcelona, Spain. andres.ozaita@upf.edu.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-634X (Electronic) Linking ISSN: 0893133X NLM ISO Abbreviation: Neuropsychopharmacology Subsets: MEDLINE
Academic Journal
Picón-Pagès P; Laboratory of Molecular Physiology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Calle Dr. Aiguader, 88, 08003 Barcelona, Spain.; Fanlo-Ucar H; Laboratory of Molecular Physiology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Calle Dr. Aiguader, 88, 08003 Barcelona, Spain.; Herrera-Fernández V; Laboratory of Molecular Physiology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Calle Dr. Aiguader, 88, 08003 Barcelona, Spain.; Ausellé-Bosch S; Laboratory of Molecular Physiology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Calle Dr. Aiguader, 88, 08003 Barcelona, Spain.; Galera-López L; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.; Gutiérrez DA; Cell Signaling Laboratory, Centro UC de Envejecimiento y Regeneración (CARE), Department of Cellular and Molecular Biology, Biological Sciences Faculty, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.; Ozaita A; Laboratory of Neuropharmacology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.; Álvarez AR; Cell Signaling Laboratory, Centro UC de Envejecimiento y Regeneración (CARE), Department of Cellular and Molecular Biology, Biological Sciences Faculty, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.; Oliva B; Laboratory of Structural Bioinformatics (GRIB), Faculty of Health and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.; Muñoz FJ; Laboratory of Molecular Physiology, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Calle Dr. Aiguader, 88, 08003 Barcelona, Spain.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Academic Journal
Busquets-Garcia A; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.; Gomis-González M; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.; Salgado-Mendialdúa V; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.; Galera-López L; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.; Puighermanal E; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.; Martín-García E; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.; Maldonado R; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.; Ozaita A; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-634X (Electronic) Linking ISSN: 0893133X NLM ISO Abbreviation: Neuropsychopharmacology Subsets: MEDLINE
Academic Journal
Blanch-Rubió J; Rheumatology Service, Hospital del Mar, Passeig Marítim, Barcelona 08003 , Spain.; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.; Soldevila-Domenech N; Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM-Institut Hospital del Mar d’Investigacions Mèdiques, PRBB, Barcelona 08003, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, Barcelona 08003, Spain.; Tío L; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.; Llorente-Onaindia J; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.; Ciria-Recasens M; Rheumatology Service, Hospital del Mar, Passeig Marítim, Barcelona 08003 , Spain.; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.; Polino L; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.; Gurt A; CAP Vila Olímpica, Parc Sanitari Pere Virgili, Barcelona 08005, Spain.; de la Torre R; Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM-Institut Hospital del Mar d’Investigacions Mèdiques, PRBB, Barcelona 08003, Spain.; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid 28029, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, Barcelona 08003, Spain.; Maldonado R; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, Barcelona 08003, Spain.; Monfort J; Rheumatology Service, Hospital del Mar, Passeig Marítim, Barcelona 08003 , Spain.; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.
Publisher: Impact Journals, LLC Country of Publication: United States NLM ID: 101508617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-4589 (Electronic) Linking ISSN: 19454589 NLM ISO Abbreviation: Aging (Albany NY) Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Galera-López, L.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어